Cost-utility analysis of 4% Tetrasodium Ethylenediaminetetraacetic Acid, Taurolidine and heparin lock to prevent central line-associated bloodstream infections in children with intestinal failure.

This model-based analysis indicates that 4% Tetrasodium EDTA can be considered the optimal strategy compared to Taurolidine and heparin in terms of cost-effectiveness. The decision uncertainty can be reduced by conducting further research on the model input parameters. An expected value of perfect information (EVPI) analysis can identify what model input parameters would be most valuable to focus on. This article is protected by copyright. All rights reserved.